KUALA LUMPUR, May 13 (Bernama) -- Indegene, a technology-led healthcare solutions provider has announced the appointment of industry commercialisation expert, Nancy Phelan, as SVP for its global digital-first omnichannel commercialisation business, based in the US.
Cofounder and EVP, Indegene, Gaurav Kapoor said in a statement: “Life sciences organisations are exploring newer ways of going to market and elevating their customer experience. Nancy’s experience leading large-scale business transformation will be especially important to translate their bold visions into reality.
“We are thrilled to have Nancy on-board to enable our clients’ new go-to-market models and drive business impact.”
Meanwhile, Phelan said: “I am very excited to join Indegene at a time when life sciences organisations are innovating at the commercial end of their value chain, just like they do at the R&D end.
“I am impressed with the Indegene team’s application of advanced analytics to understand HCPs’ digital affinity, develop and deploy omnichannel engagement plans, and optimise them continuously to maximise the benefits from digital, virtual sales and field rep channels and to further build and grow Indegene’s patient offerings.”
Phelan is a recognised life sciences thought leader, digital pioneer and change agent with 25+ years of experience in commercial strategy and operations.
Prior to Indegene, she co-led the Transformation Management Office at Novartis as its Vice President, Business Transformation and previously was VP, Head, Neuroscience Franchise Patient and Specialty Services.
At Indegene, she will lead the omnichannel commercialisation business organisation that partners with leading biopharma, emerging biotech and medical technology organisations as they rethink their Go-To-Market (GTM) models for Healthcare Professionals (HCPs) and Patients.
Through a digital-first omnichannel engagement model, Indegene helps life sciences organisations optimise their field force deployments and augment stakeholder engagement.
More details at www.indegene.com.
-- BERNAMA
No comments:
Post a Comment